| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Gain on disposal of property and equipment | - | 0 | 9,674 | - |
| Total other income (expense) | -2,106,747 | -1,987,050 | -1,447,354 | -959,025 |
| Net income (loss) from continuing operations | 834,493 | - | - | - |
| Net loss from discontinued operations (including asset impairment charge of 26,472,407 in 2025) (note 3) | -31,246,601 | - | - | - |
| Net loss | -30,412,108 | -2,018,398 | -3,527,383 | -2,883,052 |
| Net loss attributable to noncontrolling interest from continuing operations | -955 | - | - | - |
| Less total net loss attributable to noncontrolling interest | -955 | -4,036 | -206 | -25,284 |
| Net loss attributable to sanara medtech shareholders | -30,411,153 | -2,014,362 | -3,527,177 | -2,857,768 |
| Net income (loss) per share of common stock, basic | -3.52 | -0.23 | -0.41 | -0.34 |
| Net income (loss) per share of common stock, diluted | -3.4 | -0.23 | -0.41 | -0.34 |
| Weighted average number of common shares outstanding, basic | 8,646,668 | 8,612,986 | 8,570,104 | 8,517,381 |
| Weighted average number of common shares outstanding, diluted | 8,940,734 | 8,612,986 | 8,570,104 | 8,517,381 |
Sanara MedTech Inc. (SMTI)
Sanara MedTech Inc. (SMTI)